Orismilast (LEO-32731) is an orally active and selective PDE4 inhibitor used for the research of inflammatory diseases. Orismilast demonstrates potent inhibition of PDE4B and PDE4D subtype splice variants[1][2].
Molecular Weight:
510.29
Purity:
99.88
CAS Number:
[1353546-86-7]
Formula:
C19H15Cl2F2NO7S
Target:
Phosphodiesterase (PDE)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
